MYD88 and primary central nervous system lymphoma: In a small study of patients with PCNSL, MYD88 L265P mutations were detected by droplet digital PCR in plasma cfDNA in 8 of 14 patients known to harbor this mutation in their tumors (Hattori et al., 2017).